CAS 205171-12-6

(2R,3R,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)-3-methyl-tetrahydrofuran-3,4-diol

Description:

The chemical substance with the name "(2R,3R,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)-3-methyl-tetrahydrofuran-3,4-diol" and CAS number "205171-12-6" is a complex organic compound characterized by its unique structural features. It contains a purine base, which is a key component in nucleic acids, and is modified with a chloro group and a cyclopentylamino substituent, contributing to its biological activity. The tetrahydrofuran ring in the structure indicates the presence of a cyclic ether, which is significant for its solubility and reactivity. The hydroxymethyl and methyl groups suggest potential interactions with biological targets, enhancing its pharmacological properties. This compound may exhibit specific stereochemistry, as indicated by the (2R,3R,5R) configuration, which can influence its interaction with enzymes or receptors. Overall, this substance is likely to be of interest in medicinal chemistry, particularly in the development of therapeutic agents targeting nucleic acid-related processes.

Formula: C₁₆H₂₂ClN₅O₄

InChI: InChI=1/C16H22ClN5O4/c1-16(25)11(24)9(6-23)26-14(16)22-7-18-10-12(19-8-4-2-3-5-8)20-15(17)21-13(10)22/h7-9,11,14,23-25H,2-6H2,1H3,(H,19,20,21)/t9-,11?,14-,16-/m1/s1

Adenosine, 2-chloro-N-cyclopentyl-2'-C-methyl-

CAS: 205171-12-6

Formula: C₁₆H₂₂ClN₅O₄

Purity: 99%

Molecular weight: 383.8300

Ref: IN-DA0029X0

2'-MeCCPA

CAS: 205171-12-6

2'-MeCCPA

Purity: ≥98%

Molecular weight: 383.83g/mol

Ref: 54-BUP01076

2'-Meccpa

CAS: 205171-12-6

2'-Meccpa is a selective adenosine agonist that has been shown to have potential use in the treatment of atrial fibrillation. It selectively binds to the A1 receptor, which is expressed on cardiac tissues and adrenergic receptors, and activates these receptors. This drug also has anti-inflammatory properties, as it inhibits the production of inflammatory mediators such as tumor necrosis factor-α (TNF-α) and nitric oxide (NO). It can also inhibit l-type calcium channels and activate α1-adrenergic receptors. 2'-Meccpa may be used in conjunction with tecadenoson for the treatment of atrial fibrillation.

Formula: C₁₆H₂₂ClN₅O₄

Purity: Min. 95%

Molecular weight: 383.8 g/mol

Ref: 3D-FIA17112

2'-MeCCPA

CAS: 205171-12-6

2'-MeCCPA is an A1AR agonist that inhibits trichothecene-stimulated adenylate cyclase activity and has analgesic activity for the study of HCV.

Formula: C₁₆H₂₂ClN₅O₄

Purity: 99.93%

Color and Shape: Solid

Molecular weight: 383.83

Ref: TM-T22489